Clinical Trials Logo

Clinical Trial Summary

This study evaluates the safety and pharmacokinetic drug-drug interactions of omega-3 and atorvastatin in healthy male volunteers. Half of the participants will receive omega-3 for 16 days to be steady state of omega-3 and followed by omega-3 and atorvastatin in combination for 7 days. The other half will receive Atorvastatin for 7 days to be steady state of Atorvastatin, and followed by Atorvastatin and Omega-3 in combination for 16 days.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03438955
Study type Interventional
Source DongKoo Bio & Pharma
Contact Min Kyu Park, MD
Phone +82 51 240 5180
Email minkpark@dau.ac.kr
Status Recruiting
Phase Phase 1
Start date February 1, 2018
Completion date August 31, 2018